The ECHO program provides training and community for the headache patient communicators that moderate online headache communities and create headache-focused content. By connecting and investing in the people that are leading and contributing communications, this online program enhances the already strong communities and content online, expands audience size, increases organic reach via content sharing and expands PR efforts to garner more mainstream media coverage.
ECHO participants learn:
- Best practices for moderating and managing online headache communities
- Tips and tricks for creating engaging content that cuts through the digital clutter
- How to take advantage of the Facebook (and other social media) algorithms and gain increased exposure
- Packaging and pitching stories and events for broader media
There is no cost to participate in the ECHO program. Details on the 2021 ECHO program are being finalized.
The ECHO program is possible through the generosity of its sponsors: Amgen Pharmaceuticals, Novartis, Abbvie, Lilly Pharmaceuticals and Lundbeck